The mineralocorticoid receptor antagonist finerenone improves renal and cardiovascular outcomes in patients with CKD and diabetes and is currently being tested for patients with non-diabetic CKD 117,118
however, the clinical relevance of this finding in humans is uncertain, and this is not listed as a contraindication in UK or EU Summaries of Product Characteristics for licensed medicines in this class
Examples include rising blood pressure, a higher A1c, new shortness of breath, or mood changes
Semaglutide: A Head-to-Head Comparison To understand the potential advantages of tirzepatide over semaglutide, it's crucial to examine their mechanisms of action, efficacy, and side effect profiles
The effect of supplemental dietary taurine on tinnitus and auditory discrimination in an animal model
(Sigalos and Pastuszak, 2018.) On IGF-1 levels Elevated IGF-1 levels may be linked to an increased risk for some cancer types but a deceased risk for others